Exelixis
EXEL
#1643
Rank
ยฃ8.49 B
Marketcap
ยฃ29.73
Share price
-0.96%
Change (1 day)
66.71%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: ยฃ8.49 Billion

As of January 2025 Exelixis has a market cap of ยฃ8.49 Billion. This makes Exelixis the world's 1643th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ8.49 B10.35%
2024ยฃ7.69 B31.39%
2023ยฃ5.85 B36.92%
2022ยฃ4.27 B-0.19%
2021ยฃ4.28 B-6.2%
2020ยฃ4.56 B11.89%
2019ยฃ4.08 B-12.14%
2018ยฃ4.64 B-30.17%
2017ยฃ6.65 B89.96%
2016ยฃ3.50 B303.8%
2015ยฃ0.86 B378.84%
2014ยฃ0.18 B-73.58%
2013ยฃ0.68 B32.03%
2012ยฃ0.51 B25.77%
2011ยฃ0.41 B-28.95%
2010ยฃ0.58 B18.25%
2009ยฃ0.49 B35.89%
2008ยฃ0.36 B-20.51%
2007ยฃ0.45 B3.17%
2006ยฃ0.44 B-3.19%
2005ยฃ0.45 B22.77%
2004ยฃ0.37 B32.07%
2003ยฃ0.28 B-5.17%
2002ยฃ0.29 B-53.96%
2001ยฃ0.64 B40.55%
2000ยฃ0.45 B

End of Day market cap according to different sources

On Jan 16th, 2025 the market cap of Exelixis was reported to be:

ยฃ8.57 Billion
by Nasdaq info icon info icon
ยฃ8.57 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ56.01 B 559.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ104.48 B 1,130.56%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ203.43 B 2,296.05%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ93.76 B 1,004.34%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ120.12 B 1,314.86%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ290.73 B 3,324.20%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ122.40 B 1,341.69%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.87 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.42 B-94.96%๐Ÿ‡บ๐Ÿ‡ธ USA